- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x AHR: alpha-L-arabinofuranose(Non-covalent)
- 42 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.2: 4 residues within 4Å:- Chain A: Y.220, E.224
- Chain F: V.285, Y.286
Ligand excluded by PLIPMPD.3: 7 residues within 4Å:- Chain A: M.114, E.118, G.121, C.122, E.123, P.124, R.167
Ligand excluded by PLIPMPD.4: 5 residues within 4Å:- Chain A: R.20, K.64, K.376, Q.379, D.380
Ligand excluded by PLIPMPD.5: 5 residues within 4Å:- Chain A: D.260, W.263, V.264, K.267, E.398
Ligand excluded by PLIPMPD.6: 5 residues within 4Å:- Chain A: P.232, F.233, M.234, H.235, R.291
Ligand excluded by PLIPMPD.7: 4 residues within 4Å:- Chain A: P.152, N.155, W.156, E.159
Ligand excluded by PLIPMPD.8: 6 residues within 4Å:- Chain A: R.194, K.228, Q.229, P.232, F.233
- Chain C: R.185
Ligand excluded by PLIPMPD.9: 6 residues within 4Å:- Chain A: K.15, R.335, H.336, C.337, D.338, L.383
Ligand excluded by PLIPMPD.16: 4 residues within 4Å:- Chain B: Y.220, H.221, E.224
- Chain E: V.285
Ligand excluded by PLIPMPD.17: 4 residues within 4Å:- Chain B: K.15, K.290, R.335, D.338
Ligand excluded by PLIPMPD.18: 7 residues within 4Å:- Chain B: M.114, C.117, E.118, G.121, C.122, P.124, R.167
Ligand excluded by PLIPMPD.19: 4 residues within 4Å:- Chain B: D.260, W.263, V.264, E.398
Ligand excluded by PLIPMPD.20: 4 residues within 4Å:- Chain B: K.64, K.376, V.377, Q.379
Ligand excluded by PLIPMPD.21: 7 residues within 4Å:- Chain B: Q.197, K.210, P.232, F.233, M.234, H.235, R.291
Ligand excluded by PLIPMPD.22: 7 residues within 4Å:- Chain B: E.42, R.88, R.91, H.111, E.112, N.160, G.161
Ligand excluded by PLIPMPD.29: 5 residues within 4Å:- Chain C: Y.220, H.221, E.224
- Chain D: K.228, V.285
Ligand excluded by PLIPMPD.30: 4 residues within 4Å:- Chain C: R.20, K.64, Q.379, D.380
Ligand excluded by PLIPMPD.31: 5 residues within 4Å:- Chain C: D.260, W.263, V.264, K.267, E.398
Ligand excluded by PLIPMPD.32: 4 residues within 4Å:- Chain C: R.194, K.228, Q.229, P.232
Ligand excluded by PLIPMPD.33: 7 residues within 4Å:- Chain C: Q.197, K.210, P.232, F.233, M.234, H.235, R.291
Ligand excluded by PLIPMPD.34: 9 residues within 4Å:- Chain C: K.15, G.16, K.290, H.334, R.335, H.336, C.337, D.338, L.383
Ligand excluded by PLIPMPD.43: 4 residues within 4Å:- Chain C: V.285, Y.286
- Chain D: Y.220, E.224
Ligand excluded by PLIPMPD.44: 7 residues within 4Å:- Chain D: M.114, E.118, G.121, C.122, E.123, P.124, R.167
Ligand excluded by PLIPMPD.45: 5 residues within 4Å:- Chain D: R.20, K.64, K.376, Q.379, D.380
Ligand excluded by PLIPMPD.46: 5 residues within 4Å:- Chain D: D.260, W.263, V.264, K.267, E.398
Ligand excluded by PLIPMPD.47: 5 residues within 4Å:- Chain D: P.232, F.233, M.234, H.235, R.291
Ligand excluded by PLIPMPD.48: 4 residues within 4Å:- Chain D: P.152, N.155, W.156, E.159
Ligand excluded by PLIPMPD.49: 6 residues within 4Å:- Chain D: R.194, K.228, Q.229, P.232, F.233
- Chain F: R.185
Ligand excluded by PLIPMPD.50: 6 residues within 4Å:- Chain D: K.15, R.335, H.336, C.337, D.338, L.383
Ligand excluded by PLIPMPD.57: 4 residues within 4Å:- Chain B: V.285
- Chain E: Y.220, H.221, E.224
Ligand excluded by PLIPMPD.58: 4 residues within 4Å:- Chain E: K.15, K.290, R.335, D.338
Ligand excluded by PLIPMPD.59: 7 residues within 4Å:- Chain E: M.114, C.117, E.118, G.121, C.122, P.124, R.167
Ligand excluded by PLIPMPD.60: 4 residues within 4Å:- Chain E: D.260, W.263, V.264, E.398
Ligand excluded by PLIPMPD.61: 4 residues within 4Å:- Chain E: K.64, K.376, V.377, Q.379
Ligand excluded by PLIPMPD.62: 7 residues within 4Å:- Chain E: Q.197, K.210, P.232, F.233, M.234, H.235, R.291
Ligand excluded by PLIPMPD.63: 7 residues within 4Å:- Chain E: E.42, R.88, R.91, H.111, E.112, N.160, G.161
Ligand excluded by PLIPMPD.70: 5 residues within 4Å:- Chain A: K.228, V.285
- Chain F: Y.220, H.221, E.224
Ligand excluded by PLIPMPD.71: 4 residues within 4Å:- Chain F: R.20, K.64, Q.379, D.380
Ligand excluded by PLIPMPD.72: 5 residues within 4Å:- Chain F: D.260, W.263, V.264, K.267, E.398
Ligand excluded by PLIPMPD.73: 4 residues within 4Å:- Chain F: R.194, K.228, Q.229, P.232
Ligand excluded by PLIPMPD.74: 7 residues within 4Å:- Chain F: Q.197, K.210, P.232, F.233, M.234, H.235, R.291
Ligand excluded by PLIPMPD.75: 9 residues within 4Å:- Chain F: K.15, G.16, K.290, H.334, R.335, H.336, C.337, D.338, L.383
Ligand excluded by PLIP- 32 x ACT: ACETATE ION(Non-functional Binders)
ACT.10: 5 residues within 4Å:- Chain A: T.49, N.54, L.57, E.58, K.61
Ligand excluded by PLIPACT.11: 5 residues within 4Å:- Chain A: D.471, F.472, K.473, N.480, S.482
Ligand excluded by PLIPACT.12: 4 residues within 4Å:- Chain A: G.31, Y.35, V.102, I.103
Ligand excluded by PLIPACT.13: 1 residues within 4Å:- Chain A: N.373
Ligand excluded by PLIPACT.23: 4 residues within 4Å:- Chain B: T.49, L.57, E.58, K.61
Ligand excluded by PLIPACT.24: 1 residues within 4Å:- Chain B: M.153
Ligand excluded by PLIPACT.25: 5 residues within 4Å:- Chain B: D.471, F.472, K.473, N.480, S.482
Ligand excluded by PLIPACT.26: 2 residues within 4Å:- Chain B: V.102, I.103
Ligand excluded by PLIPACT.27: 1 residues within 4Å:- Chain B: P.466
Ligand excluded by PLIPACT.35: 5 residues within 4Å:- Chain C: W.39, G.41, E.42, R.88, H.107
Ligand excluded by PLIPACT.36: 4 residues within 4Å:- Chain C: T.49, L.57, E.58, K.61
Ligand excluded by PLIPACT.37: 2 residues within 4Å:- Chain C: P.152, W.156
Ligand excluded by PLIPACT.38: 5 residues within 4Å:- Chain C: D.471, F.472, K.473, N.480, S.482
Ligand excluded by PLIPACT.39: 3 residues within 4Å:- Chain C: G.31, V.102, I.103
Ligand excluded by PLIPACT.40: 3 residues within 4Å:- Chain C: K.164, P.165, R.167
Ligand excluded by PLIPACT.41: 3 residues within 4Å:- Chain C: N.373, M.374, P.466
Ligand excluded by PLIPACT.51: 5 residues within 4Å:- Chain D: T.49, N.54, L.57, E.58, K.61
Ligand excluded by PLIPACT.52: 5 residues within 4Å:- Chain D: D.471, F.472, K.473, N.480, S.482
Ligand excluded by PLIPACT.53: 4 residues within 4Å:- Chain D: G.31, Y.35, V.102, I.103
Ligand excluded by PLIPACT.54: 1 residues within 4Å:- Chain D: N.373
Ligand excluded by PLIPACT.64: 4 residues within 4Å:- Chain E: T.49, L.57, E.58, K.61
Ligand excluded by PLIPACT.65: 1 residues within 4Å:- Chain E: M.153
Ligand excluded by PLIPACT.66: 5 residues within 4Å:- Chain E: D.471, F.472, K.473, N.480, S.482
Ligand excluded by PLIPACT.67: 2 residues within 4Å:- Chain E: V.102, I.103
Ligand excluded by PLIPACT.68: 1 residues within 4Å:- Chain E: P.466
Ligand excluded by PLIPACT.76: 5 residues within 4Å:- Chain F: W.39, G.41, E.42, R.88, H.107
Ligand excluded by PLIPACT.77: 4 residues within 4Å:- Chain F: T.49, L.57, E.58, K.61
Ligand excluded by PLIPACT.78: 2 residues within 4Å:- Chain F: P.152, W.156
Ligand excluded by PLIPACT.79: 5 residues within 4Å:- Chain F: D.471, F.472, K.473, N.480, S.482
Ligand excluded by PLIPACT.80: 3 residues within 4Å:- Chain F: G.31, V.102, I.103
Ligand excluded by PLIPACT.81: 3 residues within 4Å:- Chain F: K.164, P.165, R.167
Ligand excluded by PLIPACT.82: 3 residues within 4Å:- Chain F: N.373, M.374, P.466
Ligand excluded by PLIP- 2 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
BTB.14: 6 residues within 4Å:- Chain A: G.86, P.87, R.88, R.91, E.112, N.160
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.88, A:R.88, A:E.112, A:N.160
BTB.55: 6 residues within 4Å:- Chain D: G.86, P.87, R.88, R.91, E.112, N.160
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:R.88, D:R.88, D:E.112, D:E.112, D:N.160
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, J. et al., Probing the determinants of the transglycosylation/hydrolysis partition in a retaining alpha-l-arabinofuranosidase. N Biotechnol (2021)
- Release Date
- 2021-02-10
- Peptides
- Alpha-L-arabinofuranosidase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
AE
BF
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x AHR: alpha-L-arabinofuranose(Non-covalent)
- 42 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 32 x ACT: ACETATE ION(Non-functional Binders)
- 2 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, J. et al., Probing the determinants of the transglycosylation/hydrolysis partition in a retaining alpha-l-arabinofuranosidase. N Biotechnol (2021)
- Release Date
- 2021-02-10
- Peptides
- Alpha-L-arabinofuranosidase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
AE
BF
C